FSD Pharma

FSD Pharma Launches Online System for Medicinal Cannabis Orders

Source: FSD Pharma Published on 2019-08-30

FSD Pharma Launches Online Ordering System for Medicinal Cannabis Fulfillment

Source: FSD Pharma Published on 2019-08-21

Aura Announces Pharmadrug Operational & Investor Relations Update

Source: FSD Pharma Published on 2019-08-13

FSD Pharma Appoints Larry Kaiser, MD, FACS, Dean, Lewis Katz School of Medicine at Temple University as Chairman of Its Scientific Advisory Board

Source: FSD Pharma Published on 2019-07-30

Leo Acquisitions and CBx Brands Announce Letter of Intent for Proposed Qualifying Transaction

Source: FSD Pharma Published on 2019-07-26

FSD Pharma Acquires Prismic Pharmaceuticals

Source: FSD Pharma Published on 2019-07-05

FSD Pharma Closes Deal to Acquire Prismic Pharmaceuticals

Source: FSD Pharma Published on 2019-07-02

FSD Pharma Gets License to Sell Cannabis for Medical Use

Source: FSD Pharma Published on 2019-07-01

FSD Pharma Receives Full “Sale for Medical Purposes” Cannabis License from Health Canada

Source: FSD Pharma Published on 2019-06-24

FSD Pharma Receives Full "Sale for Medical Purposes" Cannabis License from Health Canada

Source: FSD Pharma Published on 2019-06-24

FSD Pharma Continues to Add Expert Advisors Amid Buildout of Massive Facility -- CFN Media

Source: FSD Pharma Published on 2019-06-14

FSD Pharma Adds Biotech/LifeSciences Industry veteran James A. Datin and Robert J. Ciaruffoli, Former Chairman & CEO of Parente Beard/Baker Tilly to Board of Directors

Source: FSD Pharma Published on 2019-06-12

FSD Pharma Adds Biotech/LifeSciences Industry veteran James A. Datin and Robert J. Ciaruffoli, Former Chairman & CEO of Parente Beard/Baker Tilly to Board of Directors

Source: FSD Pharma Published on 2019-06-12

FSD Pharma Adds Two More Prominent Cannabis Researchers to Scientific Advisory Board

Source: FSD Pharma Published on 2019-06-06

FSD Pharma Brings in World-Renowned Experts to Build Bioscience Division -- CFN Media

Source: FSD Pharma Published on 2019-06-04

Dr. Raza Bokhari, FSD Pharma Executive Co-Chairman and CEO to Participate in Biotech-Focused Panel at the 2019 BIO International Convention

Source: FSD Pharma Published on 2019-06-03

FSD Pharma Names Raza Bokhari, M.D. as Permanent CEO

Source: FSD Pharma Published on 2019-06-03

FSD Pharma Congratulates High Tide on the Resumption of Retail Cannabis Licensing by AGLC in Alberta

Source: FSD Pharma Published on 2019-05-31

Edward Brennan, Jr., M.D., FACS to Lead FSD Pharma BioSciences Division

Source: FSD Pharma Published on 2019-05-28

FSD Pharma Welcomes All-Star Lineup of Cannabis Researchers to Scientific Advisory Board

Source: FSD Pharma Published on 2019-05-20

FSD Pharma CEO Lays Out Roadmap in Exclusive Interview with CFN Media

Source: FSD Pharma Published on 2019-05-10

FSD Pharma Investments Pay Off Amid Robust Expansion at Ontario Facility -- CFN Media

Source: FSD Pharma Published on 2019-05-08

FSD Pharma Announces Research Agreement with Solarvest to Develop Algae-based, Pharma-grade Cannabinoids

Source: FSD Pharma Published on 2019-05-07

FSD Pharma provides update on status of 2018 year-end filings

Source: FSD Pharma Published on 2019-05-02

FSD Pharma Provides Update on Status of 2018 Year-End Filings

Source: FSD Pharma Published on 2019-05-02

FSD Pharma Doubles Down on Endocannabinoid-based Pain Management -- CFN Media

Source: FSD Pharma Published on 2019-05-01

FSD Pharma Gets Approval to Get Cannabis Products

Source: FSD Pharma Published on 2019-04-29

FSD Pharma and MP Kim Rudd Host Media Event at Cobourg Production Facility

Source: FSD Pharma Published on 2019-04-26

FSD Pharma Announces Share Exchange Transaction with Aura Health

Source: FSD Pharma Published on 2019-04-24

InvestmentPitch Media Video Discusses FSD Pharma and its New Additional License to Sell Cannabis for Medical Purposes - Video Available on Investmentpitch.com

Source: FSD Pharma Published on 2019-04-23

FSD Pharma Secures Sales License for Massive Production Facility -- CFN Media

Source: FSD Pharma Published on 2019-04-23

FSD Pharma to Acquire Prismic Pharmaceuticals

Source: FSD Pharma Published on 2019-04-23

FSD Pharma Receives Cannabis Sales License from Health Canada

Source: FSD Pharma Published on 2019-04-22

FSD Pharma to Present at Arcview Investor Forum

Source: FSD Pharma Published on 2019-04-17

FSD Pharma, Experienced CEO Has Brought Good Returns for Investors, CEO Clip Video

Source: FSD Pharma Published on 2019-04-12

FSD Pharma Explores Insurance Coverage for Medical Cannabis in Canada -- CFN Media

Source: FSD Pharma Published on 2019-04-11

Cannabis Sticks to its Roots: Cannabis Companies Continue to Prioritize the Importance of “People”

Source: FSD Pharma Published on 2019-04-10

FSD Pharma Appoints Charles Pollack Jr. MD, FACEP as Chairman of the Scientific Advisory Board

Source: FSD Pharma Published on 2019-04-04

FSD Pharma to Establish Presence in Canada's Insurance Regimes

Source: FSD Pharma Published on 2019-03-28

The SunnySide of Cannabis; Cannabis Growth Boosts Solar Market

Source: FSD Pharma Published on 2019-03-21

FSD Pharma Announces New Leadership Appointment and Board Change

Source: FSD Pharma Published on 2019-03-13

FSD Pharma's Investments Provide Unique Diversification -- CFN Media

Source: FSD Pharma Published on 2019-03-05

Cannabis and Cleantech; The Green, Clean Machine of The Future

Source: FSD Pharma Published on 2019-02-27

FSD Pharma's Investments in Cutting-Edge Tech Could Pay Big Dividends -- CFN Media

Source: FSD Pharma Published on 2019-02-26

FSD Pharma Provides Update on Operations, Strategy and Leadership

Source: FSD Pharma Published on 2019-02-14

CBD Med Research and World Class Extractions Announce Signing of Definitive Agreement

Source: FSD Pharma Published on 2019-02-13

FSD Pharma Enters into Supply Agreement with Canntab Therapeutics and World Class Extractions on Organic Hemp Deal

Source: FSD Pharma Published on 2019-02-12

FSD Pharma Enters into Supply Agreement with Canntab Therapeutics and World Class Extractions on Organic Hemp Deal

Source: FSD Pharma Published on 2019-02-12

FSD Pharma to Use Pharmastrip Equipment to Make Cannabis-Infused Oral Strips

Source: FSD Pharma Published on 2019-02-11

FSD.CN

Recent Headlines

Overcoming Canada’s cannabis shortage

Flower One Signs Sale-Leaseback Agreement with Treehouse Real Estate Investment Trust, a Leading Cannabis REIT

New Ontario pot shop licences delayed until judge rules on disqualified applicants